Close to 400 Novartis Canada associates volunteered their time for various activities and projects around Quebec
Community Partnership Day symbolizes the company’s commitment to return more to society and make a difference in the communities where associates live and work
This year, Novartis associates from 53 countries are participating in the company’s 23rd annual Community Partnership Day
Dorval, May 3, 2019 – In celebration of the company’s 23rd annual Community Partnership Day, close to 400 Novartis Canada associates joined their colleagues around the world to give back to their communities. Overall, Novartis associates across six continents and 53 countries are supporting local non-profit organizations, representing more than 100,000 hours of combined community service.
“Community Partnership Day is a great opportunity for us to give back”, said Christian Macher, newly-appointed President of Novartis Pharmaceuticals Canada Inc. “I am very proud to kick off one of my first days as President supporting the communities where we live and work. Together with all Novartis associates, I feel privileged to volunteer for these invaluable organizations and to participate in this inspiring day.”
Kathleen Greenfield, Coordinator of Community Relations for Volunteer West Island (VWI) helps Novartis organize the day for Dorval-based associates through the VWI Corporate Volunteer Program. “Novartis employees often return on their own to volunteer with the groups they first get to know through Community Partnership Day. They also encourage their friends and even their children,” she said. “The groups eagerly welcome back the teams from Novartis and are very appreciative of their help.”
In the Montreal area, associates volunteered in a number of ways including cleaning, cooking and food prep, gardening, and yardwork with 11 organizations across the city, including:
Omega Community Resources.
Tyndale St-Georges Community Centre
Welcome Hall Mission
West Island Cancer Wellness Centre
Sandoz associates in Boucherville will be working on projects with several organizations in the South Shore area of Montreal throughout the year including l’École secondaire de Mortagne and la Source Bleue de Boucherville.
About Novartis in Canada Novartis Pharmaceuticals Canada Inc., a leader in the healthcare field, is committed to the discovery, development and marketing of innovative products to improve the well-being of all Canadians. In 2018, the company invested $52 million in research and development in Canada. Located in Dorval, Quebec, Novartis Pharmaceuticals Canada Inc. employs approximately 1,000 people in Canada and is an affiliate of Novartis AG, which provides innovative healthcare solutions that address the evolving needs of patients and societies. For further information, please consult www.novartis.ca.
About Sandoz in Canada Sandoz Canada is part of Sandoz International GmbH, a global leader in generic pharmaceuticals and biosimilars and a subsidiary of the Swiss multinational Novartis AG. A leader in its field, Sandoz Canada markets and distributes a broad line of generic, biosimilar, consumer and specialty products. For more information, visit www.sandoz.ca. Follow us on LinkedIn: https://www.linkedin.com/company/sandoz-canada/
About Novartis Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic and biosimilar pharmaceuticals and eye care. Novartis has leading positions globally in each of these areas. In 2018, the Group achieved net sales of USD 51.9 billion, while R&D throughout the Group amounted to approximately USD 9.1 billion. Novartis Group companies employ approximately 129,000 full-time-equivalent associates. Novartis products are sold in approximately 155 countries around the world. For more information, please visit http://www.novartis.com.